Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company’s revenues increased 20%.
Fourth-quarter revenues increased 19.7% year-over-year to $2.4 million and came in above analysts’ estimates. The company added 175 registered members during the three-month period.
Trxade reported a net loss of $0.8 million or $0.10 per share for the fourth quarter, which marked an improvement from the $2.3 million or $0.29 per share loss reported in the year-ago quarter. The bottom line also beat analysts’ estimates.
Check this space to read management/analysts’ comments on Trxade’s Q4 2021 results
Shares of Trxade closed Monday’s trading higher and continued to gain in the extended session, soon after the earnings announcement. The stock has lost about 55% in the past six months.
Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew
Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter
Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings